| 52 weeks | |||
| Year ended | ended | ||
| 30 September | 30 September | ||
| 2024 | 2023 | ||
| Note | $m | $m | |
| Continuing operations | |||
Revenue | 2.1 | ||
Cost of sales | ( | ( | |
Gross profit | |||
Sales and marketing expenses | ( | ( | |
Research and development costs | ( | ( | |
General and administrative expenses | ( | ( | |
Operating profit/(loss) | 2.1 | ( | |
Net finance costs | 5.2 | ( | ( |
Profit/(loss) before taxation | 2.5 | ( | |
Taxation | 2.6 | ||
Profit/(loss) for the period from continuing operations | ( | ||
| Discontinued operations | |||
Profit from discontinued operations | 2.2 | ||
Profit/(loss) for the period | ( | ||
| Other comprehensive income/(expense) | |||
| Items that are not subsequently reclassified to the income statement | |||
Remeasurement gain/(loss) recognised on retirement benefit scheme | 6.2 | ( | |
Deferred tax relating to retirement benefit scheme | 2.6 | ( | |
Deferred tax relating to change in tax rates | 2.6 | ||
Deferred tax relating to other temporary differences | 2.6 | ( | |
| Items that may be subsequently reclassified to the income statement | |||
Deferred tax exchange differences offset in reserves | 2.6 | ||
Other exchange differences offset in reserves | ( | ( | |
Cash flow hedges | ( | ||
Deferred tax relating to cash flow hedges | |||
Other comprehensive income/(expense) for the period | ( | ||
Total comprehensive income/(expense) for the period | ( | ||
Earnings per share | 2.3 | ||
Basic | ( | ||
Diluted | ( | ||
Earnings per share from continuing operations | 2.3 | ||
Basic | ( | ||
Diluted | ( |
| At 30 | At 30 | ||
| September | September | ||
| 2024 | 2023 | ||
| Note | $m | $m | |
| Assets | |||
| Non-current assets | |||
Intangible assets | 3.1 | ||
Property, plant and equipment | 3.2 | ||
Finance leases | 3.3 | ||
Deferred tax assets | 2.6 | ||
Derivative financial instruments | 5.4 | ||
| Current assets | |||
Inventories | 4.1 | ||
Trade and other receivables | 4.2 | ||
Derivative financial instruments | 5.4 | ||
Current tax receivables | |||
Cash and cash equivalents | 4.4 | ||
| Liabilities | |||
| Current liabilities | |||
Borrowings | 5.1 | ||
Current tax payables | |||
Trade and other payables | 4.3 | ||
Provisions for liabilities and charges | 7.1 | ||
Net current assets | |||
| Non-current liabilities | |||
Borrowings | 5.1 | ||
Derivative financial instruments | 5.4 | ||
Deferred tax liabilities | 2.6 | ||
Retirement benefit obligations | 6.2 | ||
Provisions for liabilities and charges | 7.1 | ||
Net assets | |||
| Shareholders’ equity | |||
Ordinary shares | 5.5 | ||
Share premium account | 5.5 | ||
Other reserves | ( | ( | |
Cash flow hedging reserve | |||
Retained earnings | |||
Total equity |
| 52 weeks | |||
| Year ended | ended | ||
| 30 September | 30 September | ||
| 2024 | 2023 | ||
| Note | $m | $m | |
| Cash flows from operating activities | |||
Cash flows from continuing operations | 4.4 | ||
Cash flows from discontinued operations | 4.4 | ||
Cash flows from operations | 4.4 | ||
Retirement benefit deficit recovery contributions | 6.2 | ( | |
Tax (paid)/received | ( | ||
Net cash flows from operating activities | |||
| Cash flows used in investing activities | |||
Proceeds from disposal of discontinued operations | 2.2 | ||
Costs of disposal | 2.2 | ( | |
Purchase of property, plant and equipment | 3.2 | ( | ( |
Capitalised development costs and purchased software | 3.1 | ( | ( |
Other finance income | 5.2 | ||
Finance lease capital receipts | 3.3 | ||
Net cash flows used in investing activities | ( | ( | |
| Cash flows used in financing activities | |||
Proceeds from loan drawdowns | 5.3 | ||
Loan repayments | 5.3 | ( | ( |
Finance costs paid in respect of bank loans and overdrafts | 5.2 | ( | ( |
Finance costs paid in respect of leases | 5.2 | ( | ( |
Repayment of lease liability | ( | ( | |
Dividends paid to shareholders | 5.6 | ( | ( |
Purchase of own shares – Long-Term Incentive Plan | 5.5 | ( | |
Financing cash flows used in discontinued operations | ( | ||
Net cash flows used in financing activities | ( | ( | |
Net increase in cash and cash equivalents | |||
Cash and cash equivalents at the beginning of the period | |||
Effects of exchange rate changes | |||
Cash and cash equivalents at the end of the period | 4.4 |
| Share | Share | Hedging | Other | Retained | Total | ||
| capital | premium | reserve | reserves | earnings | equity | ||
| Note | $m | $m | $m | $m | $m | $m | |
At 1 October 2022 | ( | ||||||
Loss for the period | ( | ( | |||||
Net exchange differences offset in reserves | |||||||
Deferred tax relating to other temporary differences | 2.6 | ( | ( | ||||
| Remeasurement loss recognised on retirement benefit | |||||||
scheme | 6.2 | ( | ( | ||||
Deferred tax relating to retirement benefit scheme | 2.6 | ||||||
Deferred tax relating to change in tax rates | 2.6 | ||||||
Interest rate swaps – cash flow hedge | 5.4 | ||||||
Total comprehensive income for the period | ( | ( | |||||
Dividends paid | 5.6 | ( | ( | ||||
Fair value of share-based payments | 6.3 | ||||||
| Deferred tax relating to employee share schemes | |||||||
charged directly to equity | 2.6 | ( | ( | ||||
At 30 September 2023 | ( | ||||||
Profit for the year | |||||||
Net exchange differences offset in reserves | ( | ( | |||||
Deferred tax relating to other temporary differences | 2.6 | ||||||
| Remeasurement loss recognised on retirement | |||||||
benefitscheme | 6.2 | ||||||
Deferred tax relating to retirement benefit scheme | 2.6 | ( | ( | ||||
Interest rate swaps – cash flow hedge | 5.4 | ( | ( | ||||
Total comprehensive income for the period | ( | ( | |||||
Dividends paid | 5.6 | ( | ( | ||||
Own shares acquired | 5.5 | ( | ( | ||||
Fair value of share-based payments | 6.3 | ||||||
| Deferred tax relating to employee share schemes | |||||||
charged directly to equity | 2.6 | ||||||
At 30 September 2024 | ( |
| Year ended 30 September 2024 | |||||
| Adjustments | |||||
| Avon | and | ||||
Protection | Team Wendy | Total | discontinued 1 | Total | |
$m | $m | $m | $m | $m | |
Revenue | 145.6 | 129.4 | 275.0 | - | 275.0 |
Operating profit/(loss) | 26.6 | 5.0 | 31.6 | (20.9) | 10.7 |
Finance costs | (6.3) | (2.1) | (8.4) | ||
Profit/(loss) before taxation | 25.3 | (23.0) | 2.3 | ||
Taxation | (4.4) | 5.1 | 0.7 | ||
Profit/(loss) for the period from continuing operations | 20.9 | (17.9) | 3.0 | ||
Discontinued operations – result for the year | - | - | - | ||
Profit/(loss) for the year | 20.9 | (17.9) | 3.0 | ||
Basic earnings per share (cents) | 69.9c | (59.9c) | 10.0c | ||
Diluted earnings per share (cents) | 67.6 c | (57.9c) | 9.7c |
| 52 weeks ended 30 September 2023 | |||||
| Adjustments | |||||
| Avon | and | ||||
Protection | Team Wendy | Total | discontinued 1 | Total | |
$m | $m | $m | $m | $m | |
Revenue | 156.9 | 86.9 | 243.8 | - | 243.8 |
Operating profit/(loss) | 29.3 | (8.1) | 21.2 | (33.8) | (12.6) |
Finance costs | (7.2) | (0.4) | (7.6) | ||
Profit/(loss) before taxation | 14.0 | (34.2) | (20.2) | ||
Taxation | (1.9) | 5.7 | 3.8 | ||
Profit/(loss) for the period from continuing operations | 12.1 | (28.5) | (16.4) | ||
Discontinued operations – profit for the year | - | 2.0 | 2.0 | ||
Profit/(loss) for the year | 12.1 | (26.5) | (14.4) | ||
Basic earnings per share (cents) | 40.3c | (88.3c) | (48.0c) | ||
Diluted earnings per share (cents) | 40.3c | (88.3c) | (48.0c) |
| 2024 | 2023 | |
| $m | $m | |
Europe | 42.0 | 38.2 |
US | 233.0 | 205.6 |
Total | 275.0 | 243.8 |
Year ended 30 September 2024 | 52 weeks ended 30 September 2023 | |||||
| Avon | Avon | |||||
| Protection | Team Wendy | Total | Protection | Team Wendy | Total | |
| $m | $m | $m | $m | $m | $m | |
US DOD | 39.6 | 83.1 | 122.7 | 67.1 | 42.5 | 109.6 |
Commercial Americas | 40.9 | 30.2 | 71.1 | 30.5 | 27.0 | 57.5 |
UK and International | 65.1 | 16.1 | 81.2 | 59.3 | 17.4 | 76.7 |
145.6 | 129.4 | 275.0 | 156.9 | 86.9 | 243.8 |
| 2024 | 2023 | ||
| $m | $m | ||
| Sale of goods | – point in time recognition | 225.3 | 219.7 |
| Sale of goods – over time recognition | 47. 6 | 20.4 | |
| Provision of services | – over time recognition | 2.1 | 3.7 |
275.0 | 243.8 | ||
| milkrite | | milkrite | | |||||
| Armour | InterPuls | 2024 | Armour | InterPuls | 2023 | |
| $m | $m | $m | $m | $m | $m | |
Revenue | - | - | - | 30.5 | 6.2 | 36.7 |
Cost of sales | - | - | - | (36.5) | (4.0) | (40.5) |
Gross (loss)/profit | - | - | - | (6.0) | 2.2 | (3.8) |
General and administrative expenses | - | - | - | (2.8) | - | (2.8) |
Operating (loss)/profit | - | - | - | (8.8) | 2.2 | (6.6) |
Finance costs | - | - | - | (0.2) | - | (0.2) |
(Loss)/profit before taxation | - | - | - | (9.0) | 2.2 | (6.8) |
Taxation | - | - | - | 1.8 | (0.5) | 1.3 |
(Loss)/profit from discontinued operations related to trading | - | - | - | (7. 2) | 1.7 | (5.5) |
Gain on disposal before tax | - | - | - | 9.1 | - | 9.1 |
Tax on disposal | - | - | - | (1.6) | - | (1.6) |
Gain on disposal after tax | - | - | - | 7.5 | - | 7.5 |
Total profit from discontinued operations | - | - | - | 0.3 | 1.7 | 2.0 |
Basic earnings per share | - | - | - | 1.0c | 5.7c | 6.7c |
Diluted earnings per share | - | - | - | 1.0c | 5.7c | 6.7c |
| 2023 | |
| $m | |
Cash consideration received – Lexington | 7.4 |
Cash consideration received – other assets | 0.5 |
Inventories disposed | (2.0) |
Plant and machinery disposed | (0.5) |
Finance lease adjustment | 4.1 |
Transaction costs | (0.4) |
Gain on disposal before tax | 9.1 |
Tax on disposal | (1.6) |
Gain on disposal after tax | 7.5 |
| 2024 | 2023 | |
| $m | $m | |
Cash flows from discontinued operating activities | 4.9 | 3.2 |
Financing cash flows used in discontinued operations | - | (0.9) |
Net cash flows from discontinued operations | 4.9 | 2.3 |
Weighted average number of shares | 2024 | 2023 |
Weighted average number of ordinary shares in issue used in basic calculations (‘000) | 29,895 | 29,996 |
Potentially dilutive shares (weighted average) (‘000) | 1,022 | 263 |
Diluted number of ordinary shares (weighted average) (‘000) | 30,917 | 30,259 |
| 2024 | 2023 | |
| Earnings | $m | $m |
Basic | 3.0 | (14.4) |
Basic – continuing operations | 3.0 | (16.4) |
Basic – discontinued operations | - | 2.0 |
| 2024 | 2023 | |
| Earnings per share | $ cents | $ cents |
Basic | 10.0c | (48.0c) |
Basic – continuing operations | 10.0c | (54.7c) |
Basic – discontinued operations | - | 6.7c |
Diluted | 9.7c | (48.0c) |
Diluted – continuing operations | 9.7c | (54.7c) |
Diluted – discontinued operations | - | 6.7c |
| 2024 | 2023 | |
| Continuing operations | $m | $m |
Employee and other staff costs 1 | 94.5 | 75.6 |
Legal and professional fees | 8.7 | 9.1 |
Depreciation and amortisation charges (notes 3.1 and 3.2) | 20.2 | 20.8 |
Impairment charges – non-current assets | 1.7 | 24.6 |
Foreign exchange gains | (1.0) | (1.0) |
Transportation expenses | 4.7 | 5.2 |
Material costs | 82.9 | 84.1 |
Transformational costs | 10.8 | 2.9 |
Other expenses | 41.8 | 35.1 |
Total cost of sales, selling and marketing expenses, research and development costs and general and administrative expenses | 264.3 | 256.4 |
| 2024 | 2023 | |
| Profit before taxation is shown after charging: | $m | $m |
Loss on disposal of property, plant and equipment (excluding assets related to 2023 Armour disposal, note 2.2) | - | 0.3 |
Repairs and maintenance of property, plant and equipment | 4.1 | 4.0 |
Impairment of trade receivables (note 5.4) | - | - |
| 2024 | 2023 | |
| Services provided to the Group (including its overseas subsidiaries) by the Company’s auditor: | $m | $m |
Audit fees in respect of the audit of the accounts of the Group including subsidiaries | 1.0 | 0.8 |
Audit fees in respect of the audit of the accounts of the Parent Company | 0.2 | 0.2 |
Other assurance services | 0.1 | 0.1 |
Total fees | 1.3 | 1.1 |
| 2024 | 2023 | |
| $m | $m | |
UK current tax | - | 1.1 |
UK adjustment in respect of previous periods | (0.2) | 0.6 |
Overseas current tax | - | (0.4) |
Total current tax (credit)/charge | (0.2) | 1.3 |
Deferred tax – current period | (0.2) | (4.4) |
Deferred tax – adjustment in respect of previous periods | (0.3) | (0.7) |
Total deferred tax credit | (0.5) | (5.1) |
Total tax credit | (0.7) | (3.8) |
| 2024 | 2023 | |
| $m | $m | |
Profit/(loss) before taxation | 2.3 | (20.2) |
Taxation at the average standard rate of 25.0% (2023: 22.0%) | 0.6 | (4.4) |
Other timing differences | (0.2) | - |
Non-deductible expenses | - | 0.4 |
Permanent differences | (0.7) | - |
Differences in overseas tax rates | 0.1 | 0.3 |
Adjustment in respect of previous periods | (0.5) | (0.1) |
Total tax credit | (0.7) | (3.8) |
| Accelerated | |||
| Right of use | capital | ||
| assets | allowances | Total | |
| $m | $m | $m | |
At 1 October 2022 | - | 5.8 | 5.8 |
Credited to profit for the period | - | 0.4 | 0.4 |
At 30 September 2023 | - | 6.2 | 6.2 |
Charged to profit for the year | - | 0.7 | 0.7 |
Transfer from deferred tax assets | 1.5 | - | 1.5 |
At 30 September 2024 | 1.5 | 6.9 | 8.4 |
| Retirement | Other | |||||||||
| benefit | Share | Tax | Pension | Lease | Right of | temporary | ||||
| obligation | options | losses | spreading | Intangibles | liabilities | use assets | Interest | differences | Total | |
| $m | $m | $m | $m | $m | $m | $m | $m | $m | $m | |
At 1 October 2022 | 1.6 | 0.6 | 6.4 | 2.1 | 5.9 | 3.2 | - | 1.8 | 5.1 | 26.7 |
| IAS 12 restatement at 1 | ||||||||||
October 2022 | - | - | - | - | - | 1.5 | (1.5) | - | - | - |
Credited/(charged) against profit for the period | 0.3 | 0.2 | 0.4 | (1.4) | 2.3 | (0.9) | 0.6 | 3.9 | (0.1) | 5.3 |
Credited to other comprehensive income | 6.9 | - | - | - | - | - | - | - | - | 6.9 |
| Impact of change in tax | ||||||||||
rates credited to other comprehensive income | 1.1 | - | - | - | - | - | - | - | - | 1.1 |
| Exchange differences | ||||||||||
offset in reserves | 0.2 | 0.1 | 0.1 | - | - | - | - | - | 0.4 | 0.8 |
Charged to equity | - | (0.7) | - | - | - | - | - | - | - | (0.7) |
| At 30 September 2023 | ||||||||||
(restated) | 10.1 | 0.2 | 6.9 | 0.7 | 8.2 | 3.8 | (0.9) | 5.7 | 5.4 | 40.1 |
(Charged)/credited against profit for the period | (1.5) | 0.8 | (2.6) | 1.3 | 0.2 | 0.2 | (0.6) | 1.9 | 1.5 | 1.2 |
(Charged)/credited to other comprehensive income | (5.0) | - | - | - | - | - | - | - | 0.3 | (4.7) |
| Exchange differences | ||||||||||
offset in reserves | 0.7 | 0.1 | 0.1 | 0.2 | - | - | - | - | - | 1.1 |
Credited to equity | - | 0.3 | - | - | - | - | - | - | - | 0.3 |
| Transfer to deferred tax | ||||||||||
liabilities | - | - | - | - | - | - | 1.5 | - | - | 1.5 |
At 30 September 2024 | 4.3 | 1.4 | 4.4 | 2.2 | 8.4 | 4.0 | - | 7.6 | 7. 2 | 39.5 |
| Acquired | Development | Computer | |||
| Goodwill | intangibles | expenditure | software | Total | |
| $m | $m | $m | $m | $m | |
| At 1 October 2022 | |||||
Cost | 88.7 | 98.2 | 69.2 | 15.3 | 271.4 |
Accumulated amortisation and impairment | - | (46.1) | (48.1) | (6.2) | (100.4) |
Net book amount | 88.7 | 52.1 | 21.1 | 9.1 | 171.0 |
| 52 weeks ended 30 September 2023 | |||||
Opening net book amount | 88.7 | 52.1 | 21.1 | 9.1 | 171.0 |
Exchange differences | 0.1 | - | 0.3 | - | 0.4 |
Additions | - | - | 3.1 | 0.5 | 3.6 |
Impairments | (23.4) | - | (0.2) | (0.6) | (24.2) |
Amortisation | - | (6.3) | (4.1) | (1.2) | (11.6) |
Closing net book amount | 65.4 | 45.8 | 20.2 | 7.8 | 139.2 |
| At 30 September 2023 | |||||
Cost | 88.8 | 98.2 | 69.5 | 15.0 | 271.5 |
Accumulated amortisation and impairment | (23.4) | (52.4) | (49.3) | (7.2) | (132.3) |
Net book amount | 65.4 | 45.8 | 20.2 | 7.8 | 139.2 |
| Year ended 30 September 2024 | |||||
Opening net book amount | 65.4 | 45.8 | 20.2 | 7.8 | 139.2 |
Exchange differences | - | - | 0.1 | - | 0.1 |
Additions | - | - | - | 0.6 | 0.6 |
Impairments | - | - | (1.2) | - | (1.2) |
Reclassification | - | - | (0.3) | 0.3 | - |
Amortisation | - | (6.2) | (3.1) | (3.0) | (12.3) |
Closing net book amount | 65.4 | 39.6 | 15.7 | 5.7 | 126.4 |
| At 30 September 2024 | |||||
Cost | 88.8 | 98.2 | 69.6 | 15.6 | 272.2 |
Accumulated amortisation and impairment | (23.4) | (58.6) | (53.9) | (9.9) | (145.8) |
Net book amount | 65.4 | 39.6 | 15.7 | 5.7 | 126.4 |
| Net book | |||
| Cost | Impairment | amount | |
| Allocation of goodwill by CGU | $m | $m | $m |
Avon Protection | 2.5 | - | 2.5 |
Team Wendy | 86.3 | (23.4) | 62.9 |
Total goodwill | 88.8 | (23.4) | 65.4 |
Compound annual growth rate in revenue from 2023/24 to 2028/29 | 4% |
Compound annual growth rate in gross margin from 2023/24 to 2028/29 | 8% |
| Reduction to | ||
2024 | Team | |
| Wendy CGU | ||
| value in use | ||
| $m | ||
Gross margin for all products reduced by 1.0% | 11.4 | |
Post-tax discount rate increased by 0.5% | 8.6 |
| Increase to | |
| 2024 boots | |
| and gloves | |
| CGU | |
| impairment | |
| $m | |
Revenue reduced by 20.0% | 0.6 |
Gross margin reduced by 2.5% | 0.6 |
Post-tax discount rate increased by 1.0% | 0.1 |
| At | At | At | |||
| 1 October | 30 September | 30 September | |||
| 2022 | 2023 | 2024 | |||
| Net book | Net book | Net book | |||
| amount | Amortisation | amount | Amortisation | amount | |
| $m | $m | $m | $m | $m | |
Brand | 10.4 | (1.1) | 9.3 | (1.2) | 8.1 |
Customer relationships | 25.4 | (3.0) | 22.4 | (3.0) | 19.4 |
Other intangibles | 16.3 | (2.2) | 14.1 | (2.0) | 12.1 |
Total acquired intangibles | 52.1 | (6.3) | 45.8 | (6.2) | 39.6 |
| Right of use | Plant and | Leasehold | |||
| Freeholds | lease assets | machinery | improvements | Total | |
| $m | $m | $m | $m | $m | |
| At 1 October 2022 | |||||
Cost | 3.0 | 43.2 | 96.8 | 3.9 | 146.9 |
Accumulated depreciation and impairment | (1.3) | (30.6) | (74.2) | (0.9) | (107.0) |
Net book amount | 1.7 | 12.6 | 22.6 | 3.0 | 39.9 |
| 52 weeks ended 30 September 2023 | |||||
Opening net book amount | 1.7 | 12.6 | 22.6 | 3.0 | 39.9 |
Exchange differences | - | 0.5 | 0.5 | - | 1.0 |
Additions | - | 1.1 | 7.4 | - | 8.5 |
Disposals | - | - | (0.8) | - | (0.8) |
Impairments | - | (0.5) | (0.5) | - | (1.0) |
Transfer of finance leases | - | (2.6) | - | - | (2.6) |
Depreciation charge | (0.2) | (2.6) | (5.7) | (0.7) | (9.2) |
Closing net book amount | 1.5 | 8.5 | 23.5 | 2.3 | 35.8 |
| At 30 September 2023 | |||||
Cost | 3.0 | 41.7 | 86.0 | 3.7 | 134.4 |
Accumulated depreciation and impairment | (1.5) | (33.2) | (62.5) | (1.4) | (98.6) |
Net book amount | 1.5 | 8.5 | 23.5 | 2.3 | 35.8 |
| Year ended 30 September 2024 | |||||
Opening net book amount | 1.5 | 8.5 | 23.5 | 2.3 | 35.8 |
Exchange differences | - | 0.3 | 0.6 | - | 0.9 |
Additions | - | 4.8 | 8.0 | 2.6 | 15.4 |
Impairment | - | - | (0.5) | - | (0.5) |
Depreciation charge | (0.1) | (2.7) | (4.5) | (0.6) | (7.9) |
Closing net book amount | 1.4 | 10.9 | 27.1 | 4.3 | 43.7 |
| At 30 September 2024 | |||||
Cost | 3.0 | 46.8 | 94.6 | 6.3 | 150.7 |
Accumulated depreciation and impairment | (1.6) | (35.9) | (67. 5) | (2.0) | (107.0) |
Net book amount | 1.4 | 10.9 | 27.1 | 4.3 | 43.7 |
| Finance leases | |
| $m | |
At 1 October 2022 | - |
Transfer from property, plant and equipment | 2.6 |
Additions | 4.1 |
Interest income | 0.1 |
Payments received | (0.6) |
At 30 September 2023 | 6.2 |
Additions | 0.2 |
Interest income | 0.4 |
Payments received | (1.4) |
At 30 September 2024 | 5.4 |
| 2024 | 2023 | |
| $m | $m | |
Raw materials | 27.9 | 30.1 |
Work in progress | 20.6 | 22.3 |
Finished goods | 19.7 | 14.3 |
Inventory – gross | 68.2 | 66.7 |
Inventory provisions | (13.3) | (12.3) |
Inventory – net | 54.9 | 54.4 |
| 2024 | 2023 | |
| $m | $m | |
Trade receivables | 32.6 | 54.4 |
Less: provision for impairment of receivables | (0.3) | (0.5) |
Trade receivables – net | 32.3 | 53.9 |
Prepayments | 3.4 | 3.6 |
Other receivables | 1.2 | 0.8 |
36.9 | 58.3 |
| 2024 | 2023 | |
| $m | $m | |
Trade payables | 16.2 | 17.3 |
Contract liabilities | 0.9 | 1.3 |
Other taxation and social security | 0.6 | 0.9 |
Accruals | 18.7 | 15.1 |
36.4 | 34.6 |
| 2024 | 2023 | |
| $m | $m | |
Cash and cash equivalents | 14.0 | 13.2 |
| 2024 | 2023 | |
| $m | $m | |
| Continuing operations | ||
Profit/(loss) for the period | 3.0 | (16.4) |
Taxation | (0.7) | (3.8) |
Depreciation | 7.9 | 9.2 |
Amortisation of intangible assets | 12.3 | 11. 6 |
Loss on disposal (excluding Armour sale transaction) | - | 0.3 |
Restructuring-related impairment of non-current assets | - | 0.7 |
Impairment of other non-current assets (excluding restructuring-related impairments) | 1.7 | 0.5 |
Impairment of goodwill | - | 23.4 |
Defined benefit pension scheme cost | 1.1 | 1.0 |
Net finance costs | 8.4 | 7.6 |
Fair value of share-based payments | 3.3 | 0.7 |
Transformational, restructuring and transition costs expensed | 10.8 | 2.9 |
Decrease/(increase) in inventories | 0.3 | (6.8) |
Decrease/(increase) in receivables | 17. 2 | (26.2) |
Increase/(decrease) in payables and provisions | 3.2 | (2.2) |
Cash flows from continuing operations before exceptional items | 68.5 | 2.5 |
Transformational, restructuring and transition costs paid | (9.7) | (2.3) |
Cash flows from continuing operations | 58.8 | 0.2 |
| 2024 | 2023 | |
| $m | $m | |
| Discontinued operations | ||
Profit for the period | - | 2.0 |
Taxation | - | 0.3 |
Impairments | - | 0.6 |
Net finance costs | - | 0.2 |
Gain on disposal before tax | - | (9.1) |
Decrease in inventories | - | 16.7 |
Decrease/(increase) in receivables | 5.1 | (1.3) |
Decrease in payables and provisions | (0.2) | (6.2) |
Cash flows from discontinued operations | 4.9 | 3.2 |
Cash flows from operations | 63.7 | 3.4 |
| 2024 | 2023 | |
| $m | $m | |
Change in inventories – continuing operations cash flows | (0.3) | 6.8 |
Change in inventories – discontinued operations cash flows | - | (16.7) |
Inventories disposed (note 2.2) | - | (2.0) |
Non-cash foreign exchange translation | 0.8 | 0.7 |
Balance sheet inventories movement (note 4.1) | 0.5 | (11. 2) |
| 2024 | 2023 | |
| $m | $m | |
| Current | ||
Lease liabilities | 3.9 | 4.3 |
| Non-current | ||
Bank loans | 57. 5 | 77.7 |
Lease liabilities | 18.0 | 16.6 |
75.5 | 94.3 | |
Total Group borrowings | 79.4 | 98.6 |
| 2024 | 2023 | |
| $m | $m | |
Total undrawn committed borrowing facilities | 82.5 | 127.3 |
Bank loans utilised | 57.5 | 77.7 |
Total Group facilities | 140.0 | 205.0 |
| 2024 | 2023 | |
| $m | $m | |
In one year or less, or on demand | 3.9 | 4.3 |
Two to five years | 68.2 | 86.8 |
More than five years | 7.3 | 7.5 |
Total Group borrowings | 79.4 | 98.6 |
| 2024 | 2023 | |
| $m | $m | |
Interest payable on bank loans and overdrafts | (5.4) | (6.3) |
Interest payable in respect of leases | (0.9) | (0.7) |
Amortisation of finance fees | (0.7) | (0.6) |
Net interest cost: UK defined benefit pension scheme (note 6.2) | (2.1) | (0.4) |
Other finance income | 0.7 | 0.4 |
Net finance costs | (8.4) | (7.6) |
2024 | 2023 | |||
| Sterling | Dollar | Sterling | Dollar | |
| % | % | % | % | |
Bank loans (interest payable on drawn facilities) | - | 6.89% | - | 7.76% |
Lease liabilities | 7.70% | 2.80% | 7.70% | 2.80% |
| At | At | ||||
| 30 September | Cash flow paid/ | Non-cash | Exchange | 30 September | |
| 2023 | (received) | movements | movements | 2024 | |
| $m | $m | $m | $m | $m | |
Interest due on bank loans | - | 6.1 | (6.1) | - | - |
Interest rate swaps | 0.9 | (0.7) | (0.2) | - | - |
| At | At | ||||
| 1 October | Non-cash | Exchange | 30 September | ||
| 2022 | Cash flow | movements | movements | 2023 | |
| $m | $m | $m | $m | $m | |
Interest due on bank loans | - | 6.6 | 6.6 | - | - |
Interest rate swaps | 0.5 | (0.3) | 0.7 | - | 0.9 |
| At | At | ||||
| 30 September | Non-cash | Exchange | 30 September | ||
| 2023 | Cash flow | movements | movements | 2024 | |
| $m | $m | $m | $m | $m | |
Cash and cash equivalents | 13.2 | 0.7 | - | 0.1 | 14.0 |
Bank loans | (77.7) | 20.2 | - | - | (57.5) |
Net debt excluding lease liabilities | (64.5) | 20.9 | - | 0.1 | (43.5) |
Lease liabilities | (20.9) | 5.2 | (5.7) | (0.5) | (21.9) |
Net debt | (85.4) | 26.1 | (5.7) | (0.4) | (65.4) |
| Prior RCF | New RCF initial | Other | |||
| repayment on | Other loan | drawdown | drawdown | Total | |
| cancellation | repayments | proceeds | proceeds | cash flow | |
| $m | $m | $m | $m | $m | |
Bank loans | 71.5 | 49.2 | (72.9) | (27.6) | 20.2 |
| At | At | ||||
| 1 October | Non-cash | Exchange | 30 September | ||
| 2022 | Cash flow | movements | movements | 2023 | |
| $m | $m | $m | $m | $m | |
Cash and cash equivalents | 9.5 | 3.7 | - | - | 13.2 |
Bank loans | (53.7) | (24.0) | - | - | (77.7) |
Net debt excluding lease liabilities | (44.2) | (20.3) | - | - | (64.5) |
Lease liabilities | (23.8) | 5.1 | (1.5) | (0.7) | (20.9) |
Net debt | (68.0) | (15.2) | (1.5) | (0.7) | (85.4) |
| 2024 | 2023 | |
| $m | $m | |
Repayment of lease liability – continuing operations | 4.3 | 3.5 |
Finance costs paid in respect of leases – continuing operations | 0.9 | 0.7 |
Lease cash flows related to discontinued operations | - | 0.9 |
Total lease cash flows | 5.2 | 5.1 |
| 2024 | 2023 | |
| Carrying amount of financial assets | $m | $m |
Trade receivables – net | 32.3 | 53.9 |
Other receivables | 1.2 | 0.8 |
Cash and cash equivalents | 14.0 | 13.2 |
47. 5 | 67.9 |
| 2024 | 2023 | |
| Carrying amount of financial assets | $m | $m |
Pound sterling | 4.4 | 10.0 |
US dollar | 42.5 | 56.1 |
Euro | 0.4 | 1.7 |
Other currencies | 0.2 | 0.1 |
47. 5 | 67.9 |
| Gross | Provision | Net | Gross | Provision | Net | |
| 2024 | 2024 | 2024 | 2023 | 2023 | 2023 | |
| $m | $m | $m | $m | $m | $m | |
Not past due | 28.6 | - | 28.6 | 48.8 | - | 48.8 |
Past due 0–30 days | 3.0 | - | 3.0 | 5.0 | - | 5.0 |
Past due 31–60 days | 0.5 | - | 0.5 | 0.2 | (0.1) | 0.1 |
Past due 61–90 days | 0.2 | - | 0.2 | - | - | - |
Past due 91 days | 0.3 | (0.3) | - | 0.4 | (0.4) | - |
32.6 | (0.3) | 32.3 | 54.4 | (0.5) | 53.9 |
| 2024 | 2023 | |
| $m | $m | |
At the beginning of the period | 0.5 | 0.5 |
Provision for impairment of trade receivables | (0.2) | - |
At the end of the period | 0.3 | 0.5 |
| Carrying | Contractual | Less than | After | ||
| amount | cash flows | 12 months | 2–5 years | 5 years | |
| Analysis of contractual cash flow maturities | $m | $m | $m | $m | $m |
| 30 September 2024 | |||||
Bank loans and overdrafts | (57.5) | (65.9) | (4.0) | (61.9) | - |
Trade and other payables | (34.9) | (34.9) | (34.9) | - | - |
Lease liabilities | (21.9) | (28.7) | (5.0) | (13.7) | (10.0) |
Derivatives | - | - | 0.2 | (0.2) | - |
(114 .3) | (129.5) | (43.7) | (75.8) | (10.0) |
| Carrying | Contractual | Less than | After | ||
| amount | cash flows | 12 months | 2–5 years | 5 years | |
| Analysis of contractual cash flow maturities | $m | $m | $m | $m | $m |
| 30 September 2023 | |||||
Bank loans and overdrafts | (77.7) | (87.0) | (4.7) | (82.3) | - |
Trade and other payables | (32.4) | (32.4) | (32.4) | - | - |
Lease liabilities | (20.9) | (26.8) | (5.2) | (11. 3) | (10.3) |
Derivatives | 0.9 | 0.9 | 0.3 | 0.6 | - |
(130.1) | (145.3) | (42.0) | (93.0) | (10.3) |
| Average rate | Closing rate | Average rate | Closing rate | |
| 2024 | 2024 | 2023 | 2023 | |
Pound sterling | 0.7887 | 0.7469 | 0.8163 | 0.8161 |
| 2024 | 2023 | |
| Derivative financial instruments – interest rate swaps | $m | $m |
Current | 0.2 | 0.3 |
Non-current | (0.2) | 0.6 |
- | 0.9 |
| Carrying | Carrying | |||
| amount | Fair value | amount | Fair value | |
| 2024 | 2024 | 2023 | 2023 | |
| $m | $m | $m | $m | |
Trade receivables – net | 32.3 | 32.3 | 53.9 | 53.9 |
Other receivables | 1.2 | 1.2 | 0.8 | 0.8 |
Derivatives | - | - | 0.9 | 0.9 |
Cash and cash equivalents | 14.0 | 14.0 | 13.2 | 13.2 |
Bank loans | (57.5) | (57.5) | (77.7) | (77.7) |
Trade and other payables | (35.8) | (35.8) | (33.7) | (33.7) |
| Ordinary | Share | Ordinary | Share | |||
| Number | shares | premium | Number | shares | premium | |
| of shares | 2024 | 2024 | of shares | 2023 | 2023 | |
| 2024 | $m | $m | 2023 | $m | $m | |
| Called up allotted and fully | ||||||
paid ordinary shares of £1 each At the beginning of the period | 31,023,292 | 50.3 | 54.3 | 31,023,292 | 50.3 | 54.3 |
At the end of the period | 31,023,292 | 50.3 | 54.3 | 31,023,292 | 50.3 | 54.3 |
| 2024 | 2023 | |
| Number of | Number of | |
| shares | shares | |
Opening balance | 261,714 | 261,714 |
Acquired in the period | 301,947 | - |
Disposed of on exercise of options | (8,456) | - |
Closing balance | 555,205 | 261,714 |
| 2024 | 2023 | |
| Number of | Number of | |
| shares | shares | |
Opening balance | 765,098 | 765,098 |
Acquired in the period | - | - |
Closing balance | 765,098 | 765,098 |
| 2024 | 2023 | |
| $ cents | $ cents | |
Interim dividend | 7.2c | 14.3c |
Final dividend | 16.1c | 15.3c |
Total dividend | 23.3c | 29.6c |
Basic earnings per share – continuing operations | 10.0c | (54.7c) |
Dividend cover ratio | 0.4 times | (1.8) times |
| 2024 | 2023 | |
| $m | $m | |
Wages and salaries | 71.3 | 66.8 |
Social security costs | 7.3 | 6.5 |
Other pension costs | 3.0 | 3.1 |
US healthcare costs | 5.8 | 6.1 |
Share-based payments (note 6.3) | 3.3 | 0.7 |
90.7 | 83.2 |
| 2024 | 2023 | |
| number | number | |
Avon Protection | 452 | 544 |
Team Wendy | 463 | 386 |
Armour | - | 35 |
Dairy | - | 3 |
915 | 968 |
| 2024 | 2023 | |
| number | number | |
Avon Protection | 436 | 501 |
Team Wendy | 481 | 422 |
Armour | - | 2 |
Dairy | - | 3 |
917 | 928 |
| 2024 | 2023 | |
| $m | $m | |
Salaries and other employee benefits | 5.9 | 3.1 |
Post-employment benefits | 0.2 | 0.2 |
6.1 | 3.3 |
| 2024 | 2023 | |
| $m | $m | |
Net pension liability | 17. 2 | 40.2 |
Defined benefit obligation | Defined benefit asset | Net defined benefit liability | ||||
| 2024 | 2023 | 2024 | 2023 | 2024 | 2023 | |
| $m | $m | $m | $m | $m | $m | |
At the beginning of the period | (321.7) | (284.9) | 281.5 | 278.6 | (40.2) | (6.3) |
| Included in profit or loss | ||||||
Administrative expenses | - | (1.0) | (1.1) | - | (1.1) | (1.0) |
Net interest cost | (17.7) | (16.2) | 15.6 | 15.8 | (2.1) | (0.4) |
(17.7) | (17.2) | 14.5 | 15.8 | (3.2) | (1.4) | |
| Included in other comprehensive income | ||||||
| Remeasurement gain/(loss): | ||||||
| – Actuarial gain/(loss) arising from: | ||||||
– Demographic assumptions | 7. 3 | (2.6) | - | - | 7. 3 | (2.6) |
– Financial assumptions | (11.6) | 15.0 | - | - | (11.6) | 15.0 |
– Experience adjustment | 21.1 | (24.4) | - | - | 21.1 | (24.4) |
| – Return on plan assets excluding | ||||||
interest income | - | - | 2.8 | (19.8) | 2.8 | (19.8) |
16.8 | (12.0) | 2.8 | (19.8) | 19.6 | (31.8) | |
Other Contributions by the employer | - | - | 9.1 | - | 9.1 | - |
Net benefits paid out | 22.0 | 23.7 | (22.0) | (23.7) | - | - |
FX loss | (28.7) | (31.3) | 26.2 | 30.6 | (2.5) | (0.7) |
At the end of the period | (329.3) | (321.7) | 312.1 | 281.5 | (17. 2) | (40.2) |
| 2024 | 2023 | |
| $m | $m | |
Equities and other securities | 96.2 | 83.2 |
Liability Driven Investment | 138.2 | 73.8 |
Infrastructure fund | 46.9 | 64.0 |
Other receivable | 26.1 | - |
Cash and cash equivalents | 4.7 | 60.5 |
Total fair value of assets | 312.1 | 281.5 |
| 2024 | 2023 | |
| % p.a. | % p.a. | |
Inflation (RPI) | 3.10 | 3.30 |
Inflation (CPI) | 2.70 | 2.65 |
Pension increases post-August 2005 | 2.15 | 2.10 |
Pension increases pre-August 2005 | 2.90 | 3.10 |
Discount rate for scheme liabilities | 5.05 | 5.50 |
Base mortality | Deferred members: 114% of S3PA tables | Deferred members: 114% of S3PA tables |
| Pensioners: 104% of S3PA tables | Pensioners: 104% of S3PA tables | |
| based on members’ year of birth | based on members’ year of birth | |
Future improvements in longevity | CMI 2023 projections with a long-term | CMI 2022 projections with a long-term |
| trend of 1.25% p.a. | trend of 1.50% p.a. |
2024 | 2023 | |
Male | 21.1 | 21.3 |
Female | 23.6 | 23.7 |
2024 | 2023 | |
Male | 21.6 | 22.1 |
Female | 24.4 | 24.8 |
| Defined benefit obligation | Defined benefit obligation | |
| increase/(decrease) | increase/(decrease) | |
| 2024 | 2023 | |
| $m | $m | |
Inflation (0.25% increase) | 5.7 | 5.8 |
Inflation (0.25% decrease) | (5.6) | (5.8) |
Discount rate for scheme liabilities (0.25% increase) | (8.7) | (8.4) |
Discount rate for scheme liabilities (0.25% decrease) | 9.3 | 8.8 |
Future mortality (one-year increase) | 11.7 | 10.5 |
| Number of | Number of | |
| options | options | |
| 2024 | 2023 | |
| ‘000 | ‘000 | |
Outstanding at the beginning of the period | 533 | 418 |
Forfeited and cancelled during the period | (245) | (222) |
Exercised during the period | (8) | - |
Granted during the period | 974 | 337 |
Outstanding at the end of the period | 1,254 | 533 |
Key assumptions | 2024 | 2023 |
Weighted average fair value (£) | 8.3 | 8.8 |
Closing share price at date of grant (£) | 8.5 | 10.6 |
Expected volatility (%) | N/A | 54.0 |
Risk-free interest rate (%) | N/A | 3.4 |
Expected option term, including holding period where applicable (years) | 3.6 | 3.0 |
Dividend yield (%) | - | - |
| Property | |||||||
| Warranty | Legal | obligations | Restructuring | Offset | Other | Total | |
| $m | $m | $m | $m | $m | $m | $m | |
Balance at 1 October 2022 | 2.3 | - | 3.3 | - | - | - | 5.6 |
Transferred from accruals during the period | - | - | - | - | 1.0 | - | 1.0 |
(Released)/created during the period | (0.4) | - | 0.6 | - | 1.4 | - | 1.6 |
Cash payments | (0.2) | - | - | - | - | - | (0.2) |
Foreign exchange movements | 0.1 | - | 0.3 | - | - | - | 0.4 |
Balance at 30 September 2023 | 1.8 | - | 4.2 | - | 2.4 | - | 8.4 |
Transferred from accruals during the period | - | 0.5 | - | - | - | - | 0.5 |
Created/(released) during the period | 2.6 | 0.8 | 0.6 | 1.7 | (0.9) | 0.4 | 5.2 |
Cash payments | (0.5) | - | - | (0.3) | (0.5) | - | (1.3) |
Foreign exchange movements | 0.1 | - | 0.3 | - | - | - | 0.4 |
Balance at 30 September 2024 | 4.0 | 1.3 | 5.1 | 1.4 | 1.0 | 0.4 | 13.2 |
| 2024 | 2023 | |
| Analysis of total provisions | $m | $m |
Current | 6.6 | 0.4 |
Non-current | 6.6 | 8.0 |
13.2 | 8.4 |
| 2024 | 2023 | |
| $m | $m | |
Capital expenditure committed | 1.5 | 2.4 |
| Country in which | |||||
Registered office address | Activity | incorporated | |||
| Held by Parent Company | |||||
Avon Polymer Products Limited | Hampton Park West, Melksham SN12 6NB, UK | The manufacture and distribution | UK | ||
| of respiratory protection systems | |||||
Avon Protection Holdings Limited | Hampton Park West, Melksham SN12 6NB, UK | Investment holding company | UK | ||
Avon Rubber Pension Trust Limited | Hampton Park West, Melksham SN12 6NB, UK | Pension fund trustee | UK | ||
| Held by Group undertakings | |||||
Avon Protection Systems, Inc. | 503 8th St, Cadillac, MI 49601, United States | The manufacture and distribution of respiratory | US | ||
| and ballistic protection systems | |||||
Avon Rubber & Plastics, Inc. | 503 8th St, Cadillac, MI 49601, United States | Investment holding company | US | ||
Avon Protection Ceradyne, LLC | 4000 | Barranca Parkway, Suite 100, Irvine, | The manufacture and distribution | US | |
CA | 92604, | United States | of ballistic protection systems | ||
Team Wendy LLC | 17000 | St Clair Ave, Cleveland, OH 44110, | The manufacture and distribution | US | |
| United States | of helmet systems | ||||
Avon Protection Limited | Hampton Park West, Melksham SN12 6NB, UK | Dormant company | UK | ||
Avon Protection UK Limited | Hampton Park West, Melksham SN12 6NB, UK | Dormant company | UK |